Highlight! What if Obamacare (Affordable Care Act) is repealed?
- Big Pharma’s offer to Trump: Discounts when drugs don’t work
- Advanced Curriculum for Multiple Sclerosis ’17: ACTRIMS Forum
- Patients Value Obamacare More Than General Public and Oppose Its Repeal, Survey Says
- Patient groups fear Obamacare repeal could undo protections for sickest Americans
- Most with Chronic Conditions Find Affordable Care Act Beneficial, Poll Shows
- Travel ban has serious medical consequences (Opinion)
- Nerve-insulating cells more diverse than previously thought
- Heart monitor implant could save lives in patients with serious immune disease
- ANKRD55: New gene involved in Multiple Sclerosis discovered
- In MS, can better sleep improve cognition?
- PET detects neuroinflammation in multiple sclerosis
- Multiple Sclerosis and Fibromyalgia – is there a connection? – Patient Talk
- CD8 Cells after Immunological Stem Cell Reconstitutions
- Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
- Antibodies in the CSF may be secondary to damage
- How do cells enter the Brain?
- ResearchSpeak: grey matter lesions
- Link between gut bacteria, MS discovered
- Continued inflammation in SPMS – the role of antibodies to galectin-3
- Obesity and multiple sclerosis: Is there a causal relationship?
- Gut Microbiota is different in MS
- The autoimmune predilection: rheumatoid arthritis in MS
- Tracking brain atrophy in MS could become routine, thanks to software developed at UB
- Diet and Gut Microbiome Influences Multiple Sclerosis Disease Activity
- Cerebral Microbleeds May Be Linked to Disability in Multiple Sclerosis
- ACTRIMS 2016 Talk Weighs Clinical Differences, Similarities in 2 Major Forms of MS
- Results of New SPMS Study to Be Presented at ACTRIMS
- Effects of Specific Antibodies on MS Neurodegeneration to Be Presented at ACTRIMS Forum
- Treadmill Exercise Benefits MS Patients, According to Study Presented at ACTRIMS Forum
- NIH Study into Progressive MS Biomarkers to Be Presented at ACTRIMS 2016
- ACTRIMS Session on MS Progression to Emphasize Continuing Treatment of Advancing Disease
The first month of 2015 has come and (almost) gone again. With that, it’s full steam ahead in the field of MS research, clinical trials, business news and interesting, general newsworthy bits and pieces.
This month, the highlight was the news about MS and stem cell treatment, providing a decent outlook for those looking for alternative treatment. I’ll keep following this news throughout the year, and in the meantime, check out the Highlight! section where the news was published, with usual news stories further down this web page. Continue reading “Positive MS News: January 2015”